2026 Semi-Annual Report Summary

Dian Diagnostics Group Co., Ltd.·August 20, 2026·3 pages

✨ AI Summary

This report outlines the financial performance of Dian Diagnostics for the first half of 2026. The company reported revenue of 4.77 billion RMB and a net profit attributable to shareholders of 232 million RMB, reflecting a significant year-on-year increase. No cash dividends or bonus shares are planned for this period. The company's controlling shareholder has engaged in share pledging activities, which are disclosed in accordance with regulatory requirements.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

I. Important Notes

This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should read the full report on the media designated by the China Securities Regulatory Commission. All directors attended the board meeting to review this report.

Non-standard audit opinion: No.

Profit distribution plan or capital reserve conversion plan reviewed by the Board: No. The company does not plan to distribute cash dividends, issue bonus shares, or convert capital reserves into share capital.

Preferred stock profit distribution plan approved by the Board: No.

II. Company Profile

1. Company Information

Stock Abbreviation	Dian Diagnostics	Stock Code
Stock Exchange	Shenzhen Stock Exchange
Contact Information	Board Secretary	Securities Affairs Representative
Name	Tao Jun	Fang Yun
Telephone	0571-58085608	0571-58085608
Office Address	No. 329 Jinpeng Street, Sandun Town, Xihu District, Hangzhou	No. 329 Jinpeng Street, Sandun Town, Xihu District, Hangzhou
Email	zqb@dazd.cn	zqb@dazd.cn

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.